Background In the United States, millions of patients are living with HIV and Hepatitis C (0.44% and 1.5%) and many are currently undiagnosed. Since highly effective treatments are now available, early identification of these patients is extremely important to achieve improved clinical outcomes. Prior data and trauma-associated risk factors suggest a higher prevalence of both diseases in the trauma population. We hypothesized that a screening program could be successfully initiated amongst trauma activation patients and that a referral and linkage-to-care program could be developed. Methods Hepatitis C and HIV screening tests were added to standard trauma activation lab orders at an academic Level 1 Trauma Center. Confirmatory viral load was sent when indicated. Patients with positive results were educated about their disease and referred to disease-specific follow-up. Data was collected prospectively from January 1, 2016 until June 30, 2017. Total and new diagnosis, referral rates, and linkage-to-care rates were analyzed. Results 1898 patients arrived as trauma activations. 1217 patients (64.1%) were screened (Level A = 75.6%, Level B = 60.2%). 7% of screened patients were initially positive and 5.5% were confirmed positive. Rates of both HIV (1.1%) and Hepatitis C (4.4%) were almost triple the national average. Overall, 3.3% screened positive for a new diagnosis. For Hepatitis C, the rate of new diagnosis was twice the national average (3%). Over 85% of all cases were referred for follow-up and the combined linkage-to-care rate was 43.3%. Conclusions The majority of patients were screened and referred for follow-up indicating successful implementation of our trauma screening program. Routine screening of trauma patients should be considered to increase diagnosis rate, increase linkage-to-care rates, and decrease disease transmission. These screening efforts would help bridge the health care gap that exists in the trauma population due to lower insurance rates and limited access to primary care. Level of Evidence Level III Study Type Prospective Intervention Correspondence: Alicia Privette, MD, FACS, Medical University of South Carolina, 96 Jonathan Lucas Street, MSC 613/CSB 420, Charleston, SC 29425. Tel: (843) 792-3780; Fax: (843) 792-5906 Address for reprints: Same as correspondence Conflict of Interest: No conflict of interest exists for any of the authors Meeting Presentation: 48th Annual Meeting of the Western Trauma Association, February 25 to March 2, 2018 in Whistler, Canada Funding disclosure: The authors have no funding for this project to disclose © 2018 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2LLKCoe
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
http://bit.ly/2N5roLk
-
No abstract available from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2yTOb3G
-
Abstract Our molecular understanding of the cystic fibrosis transmembrane conductance regulator (CFTR)—the chloride channel that is mutate...
-
Objectives: Severe hypoxemia is the most common serious adverse event during endotracheal intubation. Preoxygenation is performed routinely ...
-
Types of organisms and in-vitro susceptibility of bacterial isolates from patients with microbial keratitis: A trend analysis of 8 years p. ...
-
Abstract The effect of frictional boundary on the propagation of Rayleigh-type wave in an initially stressed inhomogeneous fiber-reinforce...
-
Abstract Porcine reproductive and respiratory syndrome virus (PRRSV) is leading to huge losses in the swine industry worldwide. Its nonstr...
-
Publication date: Available online 2 September 2017 Source: The Journal of Emergency Medicine Author(s): Fumihiro Ohchi, Nobuyasu Komasawa...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου